Filed pursuant to Rule 424(b)(3)

Registration No. 333-264447

PROSPECTUS SUPPLEMENT

(to Prospectus dated June 23, 2022)

 

img200035263_0.jpg
 

Terran Orbital Corporation

Up to 140,155,860 Shares of Common Stock

Up to 7,800,000 Warrants to Purchase Shares of Common Stock at $11.50 per Share

Up to 11,055,606 Warrants to Purchase Shares of Common Stock at $10.00 per Share

Up to 19,299,960 Shares of Common Stock Underlying Warrants to Purchase at $11.50 per Share

Up to 11,055,606 Shares of Common Stock Underlying Warrants to Purchase at $10.00 per Share

____________________

This prospectus supplement supplements the prospectus dated June 23, 2022 (the “Prospectus”), which forms a part of our registration statement on Form S-1 (No. 333-264447). This prospectus supplement is being filed to update and supplement the information in the Prospectus with the information contained in our Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, filed with the Securities and Exchange Commission on November 10, 2022 (the “Quarterly Report”). Accordingly, we have attached the Quarterly Report to this prospectus supplement.

The Prospectus and this prospectus supplement relate to the offer and sale from time to time by the selling securityholders named in the Prospectus (the “Selling Securityholders”) of (A) up to 140,155,860 shares of our common stock, par value $0.0001 per share (our “common stock”), consisting of (i) up to 5,080,409 shares of our common stock (the “PIPE Shares”) issued at a purchase price of $10.00 per share in a private placement pursuant to subscription agreements each entered into on October 28, 2021 (the “PIPE Financing”); (ii) up to 8,100,000 shares of our common stock (the “Founder Shares”) issued in connection with the consummation of the Business Combination (as defined in the Prospectus), in exchange for Class B ordinary shares originally issued at a price of approximately $0.003 per share in a private placement to Tailwind Two Sponsor LLC (the “Sponsor”) and Tommy Stadlen; (iii) up to 94,952,441 shares of our common stock issued or issuable to certain Selling Securityholders that are former stockholders and equity award holders of Terran Orbital (the “Legacy Terran Orbital equity holders”) in connection with or as a result of the consummation of the Business Combination, consisting of (a) up to 83,481,806 shares of our common stock originally issued to Legacy Terran Orbital stockholders at a weighted-average purchase price of approximately $0.29 per share, after giving effect to the exchange ratio in the Business Combination; (b) up to 82,616 shares of our common stock issuable upon the exercise of certain options with a weighted-average exercise price of $1.41 per share; and (c) up to 11,388,019 shares of our common stock that certain Legacy Terran Orbital equity holders have the right to receive upon the settlement of outstanding vested and unvested restricted stock unit awards upon certain conditions; (iv) up to 8,420,569 shares of our common stock issued to certain debt holders pursuant to a stock and warrant purchase agreement, which were originally issued as non-cash consideration for entering into the Francisco Partners Facility (as defined in this prospectus) and Rollover Notes (as defined in this prospectus); (v) up to 7,800,000 shares of our common stock issuable upon the exercise of the private placement warrants (as defined below); (vi) up to 11,055,606 shares of our common stock issuable upon the exercise of the debt provider warrants (as defined below); and (vii) up to 4,746,835 shares of our common stock issuable pursuant to the subscription agreement for the Insider PIPE Investor (as defined below) (with the total shares of our common stock referenced in this clause (A) being referred to herein as the “Total Resale Shares”); (B) up to 7,800,000 warrants (the “private placement warrants”) originally issued in a private placement to the Sponsor at a price of $1.50 per warrant, which private placement warrants have an exercise price of $11.50 per share; and (C) up to 11,055,606 warrants originally issued in a private placement to certain debt providers as non-cash consideration for entering into the Francisco Partner Facility and Rollover Notes, which debt provider warrants have an exercise price of $10.00 per share (the “debt provider warrants” and together with the private placement warrants, the “Offered Warrants”).

 


 

 

In addition, the Prospectus and this prospectus supplement relate to the offer and sale by us of up to: (A) 11,499,960 shares of our common stock that are issuable by us upon the exercise of 11,499,960 warrants at a price of $11.50 per share (the “public warrants” and, together with the Offered Warrants, the “Warrants”) originally issued in Tailwind Two’s (as defined in the Prospectus) initial public offering (the “IPO”) of units at a price of $10.00 per unit, which each unit consisting of one Class A ordinary share and one-third of one public warrant; (B) 7,800,000 shares of our common stock that are issuable by us upon the exercise of the private placement warrants at a price of $11.50 per share; and (C) 11,055,606 shares of our common stock that are issuable by us upon the exercise of the debt provider warrants at a price of $10.00 per share.

Our common stock is listed on the New York Stock Exchange (the “NYSE”) under the symbol “LLAP”. On November 16, 2022, the last reported sales price of our common stock was $2.67 per share and the last reported sales price of our public warrants was $0.19 per warrant.

We are an “emerging growth company” as defined in Section 2(a) of the Securities Act of 1933, as amended, and, as such, have elected to comply with certain reduced disclosure and regulatory requirements.

This prospectus supplement updates and supplements the information in the Prospectus and is not complete without, and may not be delivered or utilized except in combination with, the Prospectus, including any amendments or supplements thereto. This prospectus supplement should be read in conjunction with the Prospectus and if there is any inconsistency between the information in the Prospectus and this prospectus supplement, you should rely on the information in this prospectus supplement.

Investing in our common stock or warrants involves risks. See the section entitled “Risk Factors” beginning on page 12 of the Prospectus to read about factors you should consider before buying our securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the Prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

The date of this prospectus supplement is November 17, 2022.

ROC

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

OR

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number: 001-40170

 

TERRAN ORBITAL CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

 

 


 

 

Delaware

 

98-1572314

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer
Identification No.)

 

6800 Broken Sound Parkway NW, Suite 200

Boca Raton, FL 33487

(561) 988-1704

 

 

(Address of principal executive offices, including zip code, Registrant's telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbols

 

Name of each exchange on which registered

Common stock, par value $0.0001 per share

 

LLAP

 

New York Stock Exchange

Warrants to purchase one share of common stock, each at an exercise price of $11.50 per share

 

LLAP WS

 

New York Stock Exchange

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

 

 

Accelerated filer

 

Non-accelerated filer

 

 

Smaller reporting company

 

Emerging growth company

 

 

 

 

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

 

As of November 2, 2022, the registrant had 142,381,222 shares of common stock, $0.0001 par value per share, outstanding.

 

 

 


 

Table of Contents

 

 

 

Page

 

 

 

PART I.

FINANCIAL INFORMATION

 

 

 

 

Item 1.

Financial Statements

1

 

Condensed Consolidated Balance Sheets (Unaudited)

1

 

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

2

 

Condensed Consolidated Statements of Shareholders' Deficit (Unaudited)

3

 

Condensed Consolidated Statements of Cash Flows (Unaudited)

6

 

Notes to the Condensed Consolidated Financial Statements (Unaudited)

7

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

37

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

59

Item 4.

Controls and Procedures

59

 

 

 

PART II.

OTHER INFORMATION

 

 

 

 

Item 1.

Legal Proceedings

60

Item 1A.

Risk Factors

60

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

60

Item 3.

Defaults Upon Senior Securities

60

Item 4.

Mine Safety Disclosures

60

Item 5.

Other Information

60

Item 6.

Exhibits

61

Signatures

64

 

 


 

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements.

 

TERRAN ORBITAL CORPORATION

Condensed Consolidated Balance Sheets (Unaudited)

(In thousands, except share and per share amounts)

 

 

 

 

 

 

 

 

 

 

September 30, 2022

 

 

December 31, 2021

 

Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

35,823

 

 

$

27,325

 

Accounts receivable, net of allowance for credit losses of $234 and $945
   as of September 30, 2022 and December 31, 2021, respectively

 

 

5,039

 

 

 

3,723

 

Contract assets, net

 

 

15,013

 

 

 

2,757

 

Inventory

 

 

16,958

 

 

 

7,783

 

Prepaid expenses and other current assets

 

 

8,675

 

 

 

57,639

 

Total current assets

 

 

81,508

 

 

 

99,227

 

Property, plant, and equipment, net

 

 

48,864

 

 

 

35,530

 

Other assets

 

 

20,149

 

 

 

639

 

Total assets

 

$

150,521

 

 

$

135,396

 

Liabilities, mezzanine equity and shareholders' deficit:

 

 

 

 

 

 

Current portion of long-term debt

 

$

7,735

 

 

$

14

 

Accounts payable

 

 

19,970

 

 

 

9,366

 

Contract liabilities

 

 

34,460

 

 

 

17,558

 

Reserve for anticipated losses on contracts

 

 

1,456

 

 

 

886

 

Accrued expenses and other current liabilities

 

 

14,053

 

 

 

76,136

 

Total current liabilities

 

 

77,674

 

 

 

103,960

 

Long-term debt

 

 

99,337

 

 

 

115,134

 

Warrant liabilities

 

 

21,438

 

 

 

5,631

 

Other liabilities

 

 

19,676

 

 

 

2,028

 

Total liabilities

 

 

218,125

 

 

 

226,753

 

Commitments and contingencies (Note 12)

 

 

 

 

 

 

Mezzanine equity:

 

 

 

 

 

 

Redeemable convertible preferred stock - authorized zero and 20,526,878 shares of $0.0001 par value as of September 30, 2022 and December 31, 2021, respectively; issued and outstanding shares of zero and 10,947,686 as of September 30, 2022 and December 31, 2021, respectively

 

 

-

 

 

 

8,000

 

Shareholders' deficit:

 

 

 

 

 

 

Preferred stock - authorized 50,000,000 and zero shares of $0.0001 par value as of September 30, 2022 and December 31, 2021, respectively; zero issued and outstanding

 

 

-

 

 

 

-

 

Common stock - authorized 300,000,000 and 151,717,882 shares of $0.0001 par value as of September 30, 2022 and December 31, 2021, respectively; issued and outstanding shares of 139,962,656 and 78,601,283 as of September 30, 2022 and December 31, 2021, respectively

 

 

14

 

 

 

8

 

Additional paid-in capital

 

 

260,280

 

 

 

97,737

 

Accumulated deficit

 

 

(328,189

)

 

 

(197,066

)

Accumulated other comprehensive income (loss)

 

 

291

 

 

 

(36

)

Total shareholders' deficit

 

 

(67,604

)

 

 

(99,357

)

Total liabilities, mezzanine equity and shareholders' deficit

 

$

150,521

 

 

$

135,396

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

1


2

TERRAN ORBITAL CORPORATION

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

(In thousands, except share and per share amounts)

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2022

 

 

2021

 

 

2022

 

 

2021

 

Revenue

 

$

27,830

 

 

$

10,255

 

 

$

62,314

 

 

$

30,158

 

Cost of sales

 

 

27,793

 

 

 

8,768

 

 

 

68,784

 

 

 

23,905

 

Gross profit (loss)

 

 

37

 

 

 

1,487

 

 

 

(6,470

)

 

 

6,253

 

Selling, general, and administrative expenses

 

 

24,696

 

 

 

11,432

 

 

 

84,283

 

 

 

30,580

 

Loss from operations

 

 

(24,659

)

 

 

(9,945

)

 

 

(90,753

)

 

 

(24,327

)

Interest expense, net

 

 

7,147

 

 

 

2,630

 

 

 

17,007

 

 

 

6,174

 

Loss on extinguishment of debt

 

 

-

 

 

 

-

 

 

 

23,141

 

 

 

68,102

 

Change in fair value of warrant and derivative liabilities

 

 

(6,001

)

 

 

(205

)

 

 

(2,325

)

 

 

76

 

Other expense (income)

 

 

1,496

 

 

 

(5

)

 

 

2,367

 

 

 

28

 

Loss before income taxes

 

 

(27,301

)

 

 

(12,365

)

 

 

(130,943

)

 

 

(98,707

)

Provision for income taxes

 

 

54

 

 

 

-

 

 

 

58

 

 

 

22

 

Net loss

 

 

(27,355

)

 

 

(12,365

)

 

 

(131,001

)

 

 

(98,729

)

Other comprehensive income, net of tax:

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation adjustments

 

 

138

 

 

 

76

 

 

 

327

 

 

 

162

 

Total comprehensive loss

 

$

(27,217

)

 

$

(12,289

)

 

$

(130,674

)

 

$

(98,567

)

Weighted-average shares outstanding - basic and diluted

 

 

143,276,708

 

 

 

78,420,818

 

 

 

123,317,997

 

 

 

76,099,905

 

Net loss per share - basic and diluted

 

$

(0.19

)

 

$

(0.16

)

 

$

(1.06

)

 

$

(1.30

)

The accompanying notes are an integral part of these condensed consolidated financial statements.

2


 

TERRAN ORBITAL CORPORATION

Condensed Consolidated Statements of Shareholders’ Deficit (Unaudited)

(In thousands, except share amounts)

 

Three Months Ended September 30, 2022

 

 

Mezzanine Equity

 

 

 

Shareholders' Deficit

 

 

Redeemable Convertible Preferred Stock

 

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

 

Shares

 

 

Amount

 

 

Additional
Paid-in Capital

 

 

Accumulated
Deficit

 

 

Accumulated Other
Comprehensive Income (Loss)

 

 

Non-controlling
Interest

 

 

Total
Shareholders'
Deficit

 

Balance as of June 30, 2022

 

-

 

 

$

-

 

 

 

 

137,590,808

 

 

$

14

 

 

$

248,133

 

 

$

(300,834

)

 

$

153

 

 

$

-

 

 

$

(52,534

)

Net loss

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(27,355

)

 

 

-

 

 

 

-

 

 

 

(27,355

)

Other comprehensive income, net of tax

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

138

 

 

 

-

 

 

 

138

 

Issuance of common stock under the Committed Equity Facility

 

-

 

 

 

-

 

 

 

 

637,487

 

 

 

-

 

 

 

2,795

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,795

 

Share-based compensation

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

9,204

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

9,204

 

Settlement of vested restricted stock units

 

-

 

 

 

-

 

 

 

 

1,637,188

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercise of stock options

 

-

 

 

 

-

 

 

 

 

97,173

 

 

 

-

 

 

 

123

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

123

 

Other

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

25

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

25

 

Balance as of September 30, 2022

 

-

 

 

$

-

 

 

 

 

139,962,656

 

 

$

14

 

 

$

260,280

 

 

$

(328,189

)

 

$

291

 

 

$

-

 

 

$

(67,604

)

 

Three Months Ended September 30, 2021

 

 

Mezzanine Equity

 

 

 

Shareholders' Deficit

 

 

Redeemable Convertible Preferred Stock

 

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

 

Shares

 

 

Amount

 

 

Additional
Paid-in Capital

 

 

Accumulated
Deficit

 

 

Accumulated Other
Comprehensive Income (Loss)

 

 

Non-controlling
Interest

 

 

Total
Shareholders'
Deficit

 

Balance as of June 30, 2021

 

396,870

 

 

$

8,000

 

 

 

 

2,842,611

 

 

$

-

 

 

$

97,277

 

 

$

(144,448

)

 

$

(118

)

 

$

-

 

 

$

(47,289

)

Retroactive application of reverse recapitalization

 

10,550,816

 

 

 

-

 

 

 

 

75,571,011

 

 

 

8

 

 

 

(8

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Balance as of June 30, 2021 - Recast

 

10,947,686

 

 

$

8,000

 

 

 

 

78,413,622

 

 

$

8

 

 

$

97,269

 

 

$

(144,448

)

 

$

(118

)

 

$

-

 

 

$

(47,289

)

Net loss

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(12,365

)

 

 

-

 

 

 

-

 

 

 

(12,365

)

Other comprehensive loss, net of tax

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

76

 

 

 

-

 

 

 

76

 

Share-based compensation

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

177

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

177

 

Exercise of stock options

 

-

 

 

 

-

 

 

 

 

13,792

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Balance as of September 30, 2021

 

10,947,686

 

 

$

8,000

 

 

 

 

78,427,414

 

 

$

8

 

 

$

97,446

 

 

$

(156,813

)

 

$

(42

)

 

$

-

 

 

$

(59,401

)

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

 

3


 

TERRAN ORBITAL CORPORATION

Condensed Consolidated Statements of Shareholders’ Deficit (Unaudited)

(In thousands, except share amounts)

 

Nine Months Ended September 30, 2022

 

 

Mezzanine Equity

 

 

 

Shareholders' Deficit

 

 

Redeemable Convertible Preferred Stock

 

 

 

Common Stock

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

 

Shares

 

 

Amount

 

 

Additional
Paid-in Capital

 

 

Accumulated
Deficit

 

 

Accumulated Other
Comprehensive Income (Loss)

 

 

Non-controlling
Interest

 

 

Total
Shareholders'
Deficit

 

Balance as of December 31, 2021

 

396,870

 

 

$

8,000

 

 

 

 

2,849,414

 

 

$

-

 

 

$

97,745

 

 

$

(197,066

)

 

$

(36

)

 

$

-

 

 

$

(99,357

)

Retroactive application of reverse recapitalization

 

10,550,816

 

 

 

-

 

 

 

 

75,751,869

 

 

 

8

 

 

 

(8

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Balance as of December 31, 2021 - Recast

 

10,947,686

 

 

$

8,000

 

 

 

 

78,601,283

 

 

$

8

 

 

$

97,737

 

 

$

(197,066

)

 

$

(36

)

 

$

-

 

 

$

(99,357

)

Adoption of accounting standard, net of tax

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(122

)

 

 

-

 

 

 

-

 

 

 

(122

)

Net loss

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(131,001

)

 

 

-

 

 

 

-

 

 

 

(131,001

)

Other comprehensive income, net of tax

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

327

 

 

 

-

 

 

 

327

 

Conversion of redeemable convertible preferred stock into common stock

 

(10,947,686

)

 

 

(8,000

)

 

 

 

10,947,686

 

 

 

1

 

 

 

7,999

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

8,000

 

Net settlement of liability-classified warrants into common stock

 

-

 

 

 

-

 

 

 

 

694,873

 

 

 

-

 

 

 

7,616

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

7,616

 

Net settlement of equity-classified warrants into common stock

 

-

 

 

 

-

 

 

 

 

22,343,698

 

 

 

2

 

 

 

(2

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Issuance of common stock in connection with the Tailwind Two Merger and PIPE Investment, net of issuance costs

 

-

 

 

 

-

 

 

 

 

16,114,695

 

 

 

2

 

 

 

6,926

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,928

 

Issuance of common stock in connection with financing transactions, net of issuance costs

 

-

 

 

 

-

 

 

 

 

4,325,000

 

 

 

1

 

 

 

40,733

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

40,734

 

Reclassification of liability-classified warrants and derivatives to equity-classified

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

11,007

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

11,007

 

Issuance of contingently issuable common stock

 

-

 

 

 

-

 

 

 

 

4,095,569

 

 

 

-

 

 

 

44,887

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

44,887

 

Issuance of common stock under the Committed Equity Facility

 

-

 

 

 

-

 

 

 

 

637,487

 

 

 

-

 

 

 

2,795

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,795

 

Share-based compensation

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

40,354

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

40,354

 

Settlement of vested restricted stock units

 

-

 

 

 

-

 

 

 

 

1,932,541

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercise of stock options

 

-

 

 

 

-

 

 

 

 

269,824

 

 

 

-

 

 

 

269

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

269

 

Other

 

-

 

 

 

-

 

 

 

 

-

 

 

 

-

 

 

 

(41

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(41

)

Balance as of September 30, 2022